Chemotherapeutic agents, commonly applied in cancer diagnosis and treatment [20], could inhibit proliferation or induce cancer cell death through various molecular pathways, such as nuclear factor-κB (NF-κB) [21], vascular endothelial growth factors [22], PI3/Akt [23] and so on. This evidence concerns the gene NFKB1 and cancer.